Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction

J. T. Sylvester, J. B. Gordon, R. L. Malamet, R. C. Wetzel

Research output: Contribution to journalArticlepeer-review


Pretreatment with estradiol (20 mg IM) attenuated vasoreactivity to decreases in inspired PIO2 lowered baseline resistance measured under conditions of maximal vasodilation (PIO2 = 0 mm Hg), and appeared to increase prostaglandin release in isolated, blood-perfused lungs of juvenile female sheep. Indomethacin (40 μg/ml) inhibited prostaglandin release and restored hypoxic vasoreactivity in estrogen-treated lungs, but did not alter the estrogen-induced decrease in baseline resistance. These results suggest that estradiol enhanced the production of prostaglandins which secondarily attenuated hypoxic vasoreactivity. The estradiol-induced decrease in baseline resistance, however, must have been mediated by some other mechanism.

Original languageEnglish (US)
Pages (from-to)252S-254S
Issue number4 SUPPL.
StatePublished - 1985

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction'. Together they form a unique fingerprint.

Cite this